SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Bionano Genomics, Inc. – ‘10-K’ for 12/31/23 – ‘XML’

On:  Tuesday, 3/5/24, at 5:26pm ET   ·   For:  12/31/23   ·   Accession #:  1411690-24-13   ·   File #:  1-38613

Previous ‘10-K’:  ‘10-K’ on 3/9/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   26 References:   

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/05/24  Bionano Genomics, Inc.            10-K       12/31/23  105:13M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.40M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     31K 
 3: EX-4.5      Instrument Defining the Rights of Security Holders  HTML     42K 
 4: EX-22.1     Published Report re: Matters Submitted to a Vote    HTML     29K 
                of Security Holders                                              
 5: EX-23.1     Consent of Expert or Counsel                        HTML     28K 
10: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     51K 
                Awarded Compensation                                             
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     33K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     33K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
16: R1          Cover                                               HTML     96K 
17: R2          Audit Information                                   HTML     34K 
18: R3          Consolidated Balance Sheets                         HTML    150K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     49K 
20: R5          Consolidated Statements of Operations               HTML    110K 
21: R6          Consolidated Statements of Comprehensive Loss       HTML     55K 
22: R7          Consolidated Statements of Stockholders? Equity     HTML     95K 
                (Deficit)                                                        
23: R8          Consolidated Statements of Cash Flows               HTML    177K 
24: R9          Organization and Operations                         HTML     37K 
25: R10         Summary of Significant Accounting Policies          HTML    127K 
26: R11         Revenue from Contracts with Customers               HTML     55K 
27: R12         Investments and Fair Value Measurements             HTML    214K 
28: R13         Prepaid Expenses and Other Current Assets           HTML     41K 
29: R14         Property and Equipment, Net                         HTML     41K 
30: R15         Intangible Assets, Net                              HTML     55K 
31: R16         Accrued Expenses                                    HTML     41K 
32: R17         High Trail Agreement                                HTML     64K 
33: R18         Stockholders? Equity and Stock-Based Compensation   HTML    112K 
34: R19         Commitments and Contingencies                       HTML     81K 
35: R20         Income Taxes                                        HTML     97K 
36: R21         Employee Benefits                                   HTML     31K 
37: R22         Acquisitions                                        HTML     58K 
38: R23         Related Party Transactions                          HTML     34K 
39: R24         Pay vs Performance Disclosure                       HTML     41K 
40: R25         Insider Trading Arrangements                        HTML     35K 
41: R26         Summary of Significant Accounting Policies          HTML    161K 
                (Policies)                                                       
42: R27         Summary of Significant Accounting Policies          HTML     78K 
                (Tables)                                                         
43: R28         Revenue from Contracts with Customers (Tables)      HTML     52K 
44: R29         Investments and Fair Value Measurements (Tables)    HTML    210K 
45: R30         Prepaid Expenses and Other Current Assets (Tables)  HTML     42K 
46: R31         Property and Equipment, Net (Tables)                HTML     40K 
47: R32         Intangible Assets, Net (Tables)                     HTML     56K 
48: R33         Accrued Expenses (Tables)                           HTML     41K 
49: R34         High Trail Agreement (Tables)                       HTML     40K 
50: R35         Stockholders? Equity and Stock-Based Compensation   HTML     96K 
                (Tables)                                                         
51: R36         Commitments and Contingencies (Tables)              HTML     88K 
52: R37         Income Taxes (Tables)                               HTML     96K 
53: R38         Acquisitions (Tables)                               HTML     59K 
54: R39         Organization and Operations (Details)               HTML     72K 
55: R40         Summary of Significant Accounting Policies -        HTML    101K 
                Additional Information (Details)                                 
56: R41         Summary of Significant Accounting Policies -        HTML     36K 
                Accounts Receivable (Details)                                    
57: R42         Summary of Significant Accounting Policies -        HTML     36K 
                Changes of Allowance for Credit Losses (Details)                 
58: R43         Summary of Significant Accounting Policies -        HTML     42K 
                Inventories (Details)                                            
59: R44         Summary of Significant Accounting Policies -        HTML     41K 
                Goodwill (Details)                                               
60: R45         Summary of Significant Accounting Policies -        HTML     44K 
                Potentially Dilutive Securities not Included in                  
                Calculation of Diluted Net Loss Per Share                        
                Attributable to Common Stockholders (Details)                    
61: R46         Revenue from Contracts with Customers (Details)     HTML     67K 
62: R47         Investments and Fair Value Measurements -           HTML    104K 
                Financial Assets and Liabilities (Details)                       
63: R48         Investments and Fair Value Measurements -           HTML     91K 
                Additional Information (Details)                                 
64: R49         Investments and Fair Value Measurements -           HTML     63K 
                Estimated Fair Value Assumption (Details)                        
65: R50         Investments and Fair Value Measurements - Level 3   HTML     58K 
                Measurement (Details)                                            
66: R51         Investments and Fair Value Measurements -           HTML     85K 
                Amortized Cost and Unrealized Gains (Losses)                     
                (Details)                                                        
67: R52         Investments and Fair Value Measurements -           HTML     71K 
                Unrealized Losses Positions (Details)                            
68: R53         Prepaid Expenses and Other Current Assets           HTML     48K 
                (Details)                                                        
69: R54         Property and Equipment, Net - Property and          HTML     46K 
                Equipment, net (Details)                                         
70: R55         Property and Equipment, Net - Additional            HTML     33K 
                Information (Details)                                            
71: R56         Intangible Assets, Net - Intangible Assets          HTML     44K 
                (Details)                                                        
72: R57         Intangible Assets, Net - Additional Information     HTML     47K 
                (Details)                                                        
73: R58         Intangible Assets, Net - Future Amortization of     HTML     44K 
                Intangible Assets (Details)                                      
74: R59         Accrued Expenses (Details)                          HTML     48K 
75: R60         High Trail Agreement - Additional Information       HTML    163K 
                (Details)                                                        
76: R61         High Trail Agreement - Schedule of Convertible      HTML     43K 
                Debt (Details)                                                   
77: R62         High Trail Agreement - Schedule of Future           HTML     44K 
                Aggregate Redemption (Details)                                   
78: R63         Stockholders? Equity and Stock-Based Compensation   HTML    228K 
                - Additional Information (Details)                               
79: R64         Stockholders? Equity and Stock-Based Compensation   HTML     57K 
                - Warrant Activity (Details)                                     
80: R65         Stockholders? Equity and Stock-Based Compensation   HTML     73K 
                - Stock Option Activity (Details)                                
81: R66         Stockholders? Equity and Stock-Based Compensation   HTML     60K 
                - Restricted Stock and Performance Stock Activity                
                (Details)                                                        
82: R67         Stockholders? Equity and Stock-Based Compensation   HTML     49K 
                - Recognized Stock-Based Compensation Expense                    
                (Details)                                                        
83: R68         Stockholders? Equity and Stock-Based Compensation   HTML     38K 
                - Assumptions (Details)                                          
84: R69         Commitments and Contingencies - Additional          HTML     80K 
                Information (Details)                                            
85: R70         Commitments and Contingencies - Supplemental        HTML     52K 
                Information (Details)                                            
86: R71         Commitments and Contingencies - Lease Cost          HTML     48K 
                (Details)                                                        
87: R72         Commitments and Contingencies - Undiscounted        HTML     77K 
                Future Non-Cancellable Lease Payments Under Leases               
                (Details)                                                        
88: R73         Income Taxes - Domestic and Foreign Components of   HTML     38K 
                Income (Loss) (Details)                                          
89: R74         Income Taxes - Provision for Domestic and Foreign   HTML     56K 
                Income Taxes (Details)                                           
90: R75         Income Taxes - Effective Income Tax Rate            HTML     56K 
                Reconciliation (Details)                                         
91: R76         Income Taxes - Deferred Tax Assets (Details)        HTML     54K 
92: R77         Income Taxes - Additional Information (Details)     HTML     71K 
93: R78         Income Taxes - Unrecognized Tax Benefits (Details)  HTML     38K 
94: R79         Employee Benefits (Details)                         HTML     30K 
95: R80         Acquisitions - Additional Information (Details)     HTML     47K 
96: R81         Acquisitions - Acquisition Purchase Price           HTML     39K 
                (Details)                                                        
97: R82         Acquisitions - Fair Value of Tangible and           HTML     64K 
                Identifiable Assets Acquired and Liabilities                     
                Assumed (Details)                                                
98: R83         Acquisitions - Identifiable Intangible Assets       HTML     39K 
                (Details)                                                        
99: R84         Acquisitions - Pro Forma Information (Details)      HTML     38K 
100: R85         Related Party Transactions (Details)                HTML     34K  
102: XML         IDEA XML File -- Filing Summary                      XML    188K  
105: XML         XBRL Instance -- bngo-20231231_htm                   XML   2.55M  
101: EXCEL       IDEA Workbook of Financial Report Info              XLSX    220K  
12: EX-101.CAL  XBRL Calculations -- bngo-20231231_cal               XML    346K 
13: EX-101.DEF  XBRL Definitions -- bngo-20231231_def                XML    979K 
14: EX-101.LAB  XBRL Labels -- bngo-20231231_lab                     XML   2.50M 
15: EX-101.PRE  XBRL Presentations -- bngo-20231231_pre              XML   1.65M 
11: EX-101.SCH  XBRL Schema -- bngo-20231231                         XSD    244K 
103: JSON        XBRL Instance as JSON Data -- MetaLinks              710±  1.08M  
104: ZIP         XBRL Zipped Folder -- 0001411690-24-000013-xbrl      Zip   1.03M

‘XML’   —   IDEA XML File — Filing Summary

This Document is an IDEA XML File.

                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<FilingSummary>
<Version> 3.24.0.1 </Version>
<ProcessingTime/>
<ReportFormat> html </ReportFormat>
<ContextCount> 350 </ContextCount>
<ElementCount> 560 </ElementCount>
<EntityCount> 1 </EntityCount>
<FootnotesReported> false </FootnotesReported>
<SegmentCount> 104 </SegmentCount>
<ScenarioCount> 0 </ScenarioCount>
<TuplesReported> false </TuplesReported>
<UnitCount> 13 </UnitCount>
<MyReports>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R1.htm </HtmlFileName>
<LongName> 0000001 - Document - Cover </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/Cover </Role>
<ShortName> Cover </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 1 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R2.htm </HtmlFileName>
<LongName> 0000002 - Document - Audit Information </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AuditInformation </Role>
<ShortName> Audit Information </ShortName>
<MenuCategory> Cover </MenuCategory>
<Position> 2 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R3.htm </HtmlFileName>
<LongName> 0000003 - Statement - Consolidated Balance Sheets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/ConsolidatedBalanceSheets </Role>
<ShortName> Consolidated Balance Sheets </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 3 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R4.htm </HtmlFileName>
<LongName> 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/ConsolidatedBalanceSheetsParenthetical </Role>
<ShortName> Consolidated Balance Sheets (Parenthetical) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 4 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R5.htm </HtmlFileName>
<LongName> 0000005 - Statement - Consolidated Statements of Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/ConsolidatedStatementsofOperations </Role>
<ShortName> Consolidated Statements of Operations </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 5 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R6.htm </HtmlFileName>
<LongName> 0000006 - Statement - Consolidated Statements of Comprehensive Loss </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/ConsolidatedStatementsofComprehensiveLoss </Role>
<ShortName> Consolidated Statements of Comprehensive Loss </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 6 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R7.htm </HtmlFileName>
<LongName> 0000007 - Statement - Consolidated Statements of Stockholders??? Equity (Deficit) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/ConsolidatedStatementsofStockholdersEquityDeficit </Role>
<ShortName> Consolidated Statements of Stockholders??? Equity (Deficit) </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 7 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R8.htm </HtmlFileName>
<LongName> 0000008 - Statement - Consolidated Statements of Cash Flows </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/ConsolidatedStatementsofCashFlows </Role>
<ShortName> Consolidated Statements of Cash Flows </ShortName>
<MenuCategory> Statements </MenuCategory>
<Position> 8 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R9.htm </HtmlFileName>
<LongName> 0000009 - Disclosure - Organization and Operations </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/OrganizationandOperations </Role>
<ShortName> Organization and Operations </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 9 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R10.htm </HtmlFileName>
<LongName> 0000010 - Disclosure - Summary of Significant Accounting Policies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPolicies </Role>
<ShortName> Summary of Significant Accounting Policies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 10 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R11.htm </HtmlFileName>
<LongName> 0000011 - Disclosure - Revenue from Contracts with Customers </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/RevenuefromContractswithCustomers </Role>
<ShortName> Revenue from Contracts with Customers </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 11 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R12.htm </HtmlFileName>
<LongName> 0000012 - Disclosure - Investments and Fair Value Measurements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurements </Role>
<ShortName> Investments and Fair Value Measurements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 12 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R13.htm </HtmlFileName>
<LongName> 0000013 - Disclosure - Prepaid Expenses and Other Current Assets </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/PrepaidExpensesandOtherCurrentAssets </Role>
<ShortName> Prepaid Expenses and Other Current Assets </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 13 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R14.htm </HtmlFileName>
<LongName> 0000014 - Disclosure - Property and Equipment, Net </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/PropertyandEquipmentNet </Role>
<ShortName> Property and Equipment, Net </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 14 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R15.htm </HtmlFileName>
<LongName> 0000015 - Disclosure - Intangible Assets, Net </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IntangibleAssetsNet </Role>
<ShortName> Intangible Assets, Net </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 15 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R16.htm </HtmlFileName>
<LongName> 0000016 - Disclosure - Accrued Expenses </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AccruedExpenses </Role>
<ShortName> Accrued Expenses </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 16 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R17.htm </HtmlFileName>
<LongName> 0000017 - Disclosure - High Trail Agreement </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/HighTrailAgreement </Role>
<ShortName> High Trail Agreement </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 17 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R18.htm </HtmlFileName>
<LongName> 0000018 - Disclosure - Stockholders??? Equity and Stock-Based Compensation </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensation </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 18 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R19.htm </HtmlFileName>
<LongName> 0000019 - Disclosure - Commitments and Contingencies </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/CommitmentsandContingencies </Role>
<ShortName> Commitments and Contingencies </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 19 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R20.htm </HtmlFileName>
<LongName> 0000020 - Disclosure - Income Taxes </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IncomeTaxes </Role>
<ShortName> Income Taxes </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 20 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R21.htm </HtmlFileName>
<LongName> 0000021 - Disclosure - Employee Benefits </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/EmployeeBenefits </Role>
<ShortName> Employee Benefits </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 21 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R22.htm </HtmlFileName>
<LongName> 0000022 - Disclosure - Acquisitions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/Acquisitions </Role>
<ShortName> Acquisitions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 22 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R23.htm </HtmlFileName>
<LongName> 0000023 - Disclosure - Related Party Transactions </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/RelatedPartyTransactions </Role>
<ShortName> Related Party Transactions </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 23 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R24.htm </HtmlFileName>
<LongName> 995410 - Disclosure - Pay vs Performance Disclosure </LongName>
<ReportType> Sheet </ReportType>
<Role> http://xbrl.sec.gov/ecd/role/PvpDisclosure </Role>
<ShortName> Pay vs Performance Disclosure </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 24 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R25.htm </HtmlFileName>
<LongName> 995445 - Disclosure - Insider Trading Arrangements </LongName>
<ReportType> Sheet </ReportType>
<Role> http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements </Role>
<ShortName> Insider Trading Arrangements </ShortName>
<MenuCategory> Notes </MenuCategory>
<Position> 25 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R26.htm </HtmlFileName>
<LongName> 9954471 - Disclosure - Summary of Significant Accounting Policies (Policies) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPoliciesPolicies </Role>
<ShortName> Summary of Significant Accounting Policies (Policies) </ShortName>
<MenuCategory> Policies </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 26 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R27.htm </HtmlFileName>
<LongName> 9954472 - Disclosure - Summary of Significant Accounting Policies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPoliciesTables </Role>
<ShortName> Summary of Significant Accounting Policies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/SummaryofSignificantAccountingPolicies </ParentRole>
<Position> 27 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R28.htm </HtmlFileName>
<LongName> 9954473 - Disclosure - Revenue from Contracts with Customers (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/RevenuefromContractswithCustomersTables </Role>
<ShortName> Revenue from Contracts with Customers (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/RevenuefromContractswithCustomers </ParentRole>
<Position> 28 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R29.htm </HtmlFileName>
<LongName> 9954474 - Disclosure - Investments and Fair Value Measurements (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurementsTables </Role>
<ShortName> Investments and Fair Value Measurements (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurements </ParentRole>
<Position> 29 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R30.htm </HtmlFileName>
<LongName> 9954475 - Disclosure - Prepaid Expenses and Other Current Assets (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/PrepaidExpensesandOtherCurrentAssetsTables </Role>
<ShortName> Prepaid Expenses and Other Current Assets (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/PrepaidExpensesandOtherCurrentAssets </ParentRole>
<Position> 30 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R31.htm </HtmlFileName>
<LongName> 9954476 - Disclosure - Property and Equipment, Net (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/PropertyandEquipmentNetTables </Role>
<ShortName> Property and Equipment, Net (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/PropertyandEquipmentNet </ParentRole>
<Position> 31 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R32.htm </HtmlFileName>
<LongName> 9954477 - Disclosure - Intangible Assets, Net (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IntangibleAssetsNetTables </Role>
<ShortName> Intangible Assets, Net (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/IntangibleAssetsNet </ParentRole>
<Position> 32 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R33.htm </HtmlFileName>
<LongName> 9954478 - Disclosure - Accrued Expenses (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AccruedExpensesTables </Role>
<ShortName> Accrued Expenses (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/AccruedExpenses </ParentRole>
<Position> 33 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R34.htm </HtmlFileName>
<LongName> 9954479 - Disclosure - High Trail Agreement (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/HighTrailAgreementTables </Role>
<ShortName> High Trail Agreement (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/HighTrailAgreement </ParentRole>
<Position> 34 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R35.htm </HtmlFileName>
<LongName> 9954480 - Disclosure - Stockholders??? Equity and Stock-Based Compensation (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensationTables </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensation </ParentRole>
<Position> 35 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R36.htm </HtmlFileName>
<LongName> 9954481 - Disclosure - Commitments and Contingencies (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/CommitmentsandContingenciesTables </Role>
<ShortName> Commitments and Contingencies (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/CommitmentsandContingencies </ParentRole>
<Position> 36 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R37.htm </HtmlFileName>
<LongName> 9954482 - Disclosure - Income Taxes (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IncomeTaxesTables </Role>
<ShortName> Income Taxes (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/IncomeTaxes </ParentRole>
<Position> 37 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R38.htm </HtmlFileName>
<LongName> 9954483 - Disclosure - Acquisitions (Tables) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AcquisitionsTables </Role>
<ShortName> Acquisitions (Tables) </ShortName>
<MenuCategory> Tables </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/Acquisitions </ParentRole>
<Position> 38 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R39.htm </HtmlFileName>
<LongName> 9954484 - Disclosure - Organization and Operations (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/OrganizationandOperationsDetails </Role>
<ShortName> Organization and Operations (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/OrganizationandOperations </ParentRole>
<Position> 39 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R40.htm </HtmlFileName>
<LongName> 9954485 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 40 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R41.htm </HtmlFileName>
<LongName> 9954486 - Disclosure - Summary of Significant Accounting Policies - Accounts Receivable (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPoliciesAccountsReceivableDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Accounts Receivable (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 41 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R42.htm </HtmlFileName>
<LongName> 9954487 - Disclosure - Summary of Significant Accounting Policies - Changes of Allowance for Credit Losses (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPoliciesChangesofAllowanceforCreditLossesDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Changes of Allowance for Credit Losses (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 42 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R43.htm </HtmlFileName>
<LongName> 9954488 - Disclosure - Summary of Significant Accounting Policies - Inventories (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPoliciesInventoriesDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Inventories (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 43 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R44.htm </HtmlFileName>
<LongName> 9954489 - Disclosure - Summary of Significant Accounting Policies - Goodwill (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPoliciesGoodwillDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Goodwill (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 44 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R45.htm </HtmlFileName>
<LongName> 9954490 - Disclosure - Summary of Significant Accounting Policies - Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/SummaryofSignificantAccountingPoliciesPotentiallyDilutiveSecuritiesnotIncludedinCalculationofDilutedNetLossPerShareAttributabletoCommonStockholdersDetails </Role>
<ShortName> Summary of Significant Accounting Policies - Potentially Dilutive Securities not Included in Calculation of Diluted Net Loss Per Share Attributable to Common Stockholders (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 45 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R46.htm </HtmlFileName>
<LongName> 9954491 - Disclosure - Revenue from Contracts with Customers (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/RevenuefromContractswithCustomersDetails </Role>
<ShortName> Revenue from Contracts with Customers (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/RevenuefromContractswithCustomersTables </ParentRole>
<Position> 46 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R47.htm </HtmlFileName>
<LongName> 9954492 - Disclosure - Investments and Fair Value Measurements - Financial Assets and Liabilities (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurementsFinancialAssetsandLiabilitiesDetails </Role>
<ShortName> Investments and Fair Value Measurements - Financial Assets and Liabilities (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 47 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R48.htm </HtmlFileName>
<LongName> 9954493 - Disclosure - Investments and Fair Value Measurements - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurementsAdditionalInformationDetails </Role>
<ShortName> Investments and Fair Value Measurements - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 48 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R49.htm </HtmlFileName>
<LongName> 9954494 - Disclosure - Investments and Fair Value Measurements - Estimated Fair Value Assumption (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurementsEstimatedFairValueAssumptionDetails </Role>
<ShortName> Investments and Fair Value Measurements - Estimated Fair Value Assumption (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 49 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R50.htm </HtmlFileName>
<LongName> 9954495 - Disclosure - Investments and Fair Value Measurements - Level 3 Measurement (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurementsLevel3MeasurementDetails </Role>
<ShortName> Investments and Fair Value Measurements - Level 3 Measurement (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 50 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R51.htm </HtmlFileName>
<LongName> 9954496 - Disclosure - Investments and Fair Value Measurements - Amortized Cost and Unrealized Gains (Losses) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurementsAmortizedCostandUnrealizedGainsLossesDetails </Role>
<ShortName> Investments and Fair Value Measurements - Amortized Cost and Unrealized Gains (Losses) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 51 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R52.htm </HtmlFileName>
<LongName> 9954497 - Disclosure - Investments and Fair Value Measurements - Unrealized Losses Positions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/InvestmentsandFairValueMeasurementsUnrealizedLossesPositionsDetails </Role>
<ShortName> Investments and Fair Value Measurements - Unrealized Losses Positions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 52 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R53.htm </HtmlFileName>
<LongName> 9954498 - Disclosure - Prepaid Expenses and Other Current Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/PrepaidExpensesandOtherCurrentAssetsDetails </Role>
<ShortName> Prepaid Expenses and Other Current Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/PrepaidExpensesandOtherCurrentAssetsTables </ParentRole>
<Position> 53 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R54.htm </HtmlFileName>
<LongName> 9954499 - Disclosure - Property and Equipment, Net - Property and Equipment, net (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/PropertyandEquipmentNetPropertyandEquipmentnetDetails </Role>
<ShortName> Property and Equipment, Net - Property and Equipment, net (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 54 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R55.htm </HtmlFileName>
<LongName> 9954500 - Disclosure - Property and Equipment, Net - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/PropertyandEquipmentNetAdditionalInformationDetails </Role>
<ShortName> Property and Equipment, Net - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 55 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R56.htm </HtmlFileName>
<LongName> 9954501 - Disclosure - Intangible Assets, Net - Intangible Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IntangibleAssetsNetIntangibleAssetsDetails </Role>
<ShortName> Intangible Assets, Net - Intangible Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 56 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R57.htm </HtmlFileName>
<LongName> 9954502 - Disclosure - Intangible Assets, Net - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IntangibleAssetsNetAdditionalInformationDetails </Role>
<ShortName> Intangible Assets, Net - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 57 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R58.htm </HtmlFileName>
<LongName> 9954503 - Disclosure - Intangible Assets, Net - Future Amortization of Intangible Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IntangibleAssetsNetFutureAmortizationofIntangibleAssetsDetails </Role>
<ShortName> Intangible Assets, Net - Future Amortization of Intangible Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 58 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R59.htm </HtmlFileName>
<LongName> 9954504 - Disclosure - Accrued Expenses (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AccruedExpensesDetails </Role>
<ShortName> Accrued Expenses (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/AccruedExpensesTables </ParentRole>
<Position> 59 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R60.htm </HtmlFileName>
<LongName> 9954505 - Disclosure - High Trail Agreement - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/HighTrailAgreementAdditionalInformationDetails </Role>
<ShortName> High Trail Agreement - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 60 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R61.htm </HtmlFileName>
<LongName> 9954506 - Disclosure - High Trail Agreement - Schedule of Convertible Debt (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/HighTrailAgreementScheduleofConvertibleDebtDetails </Role>
<ShortName> High Trail Agreement - Schedule of Convertible Debt (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 61 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R62.htm </HtmlFileName>
<LongName> 9954507 - Disclosure - High Trail Agreement - Schedule of Future Aggregate Redemption (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/HighTrailAgreementScheduleofFutureAggregateRedemptionDetails </Role>
<ShortName> High Trail Agreement - Schedule of Future Aggregate Redemption (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 62 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R63.htm </HtmlFileName>
<LongName> 9954508 - Disclosure - Stockholders??? Equity and Stock-Based Compensation - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensationAdditionalInformationDetails </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 63 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R64.htm </HtmlFileName>
<LongName> 9954509 - Disclosure - Stockholders??? Equity and Stock-Based Compensation - Warrant Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensationWarrantActivityDetails </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation - Warrant Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 64 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R65.htm </HtmlFileName>
<LongName> 9954510 - Disclosure - Stockholders??? Equity and Stock-Based Compensation - Stock Option Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensationStockOptionActivityDetails </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation - Stock Option Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 65 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R66.htm </HtmlFileName>
<LongName> 9954511 - Disclosure - Stockholders??? Equity and Stock-Based Compensation - Restricted Stock and Performance Stock Activity (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensationRestrictedStockandPerformanceStockActivityDetails </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation - Restricted Stock and Performance Stock Activity (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 66 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R67.htm </HtmlFileName>
<LongName> 9954512 - Disclosure - Stockholders??? Equity and Stock-Based Compensation - Recognized Stock-Based Compensation Expense (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensationRecognizedStockBasedCompensationExpenseDetails </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation - Recognized Stock-Based Compensation Expense (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 67 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R68.htm </HtmlFileName>
<LongName> 9954513 - Disclosure - Stockholders??? Equity and Stock-Based Compensation - Assumptions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/StockholdersEquityandStockBasedCompensationAssumptionsDetails </Role>
<ShortName> Stockholders??? Equity and Stock-Based Compensation - Assumptions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 68 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R69.htm </HtmlFileName>
<LongName> 9954514 - Disclosure - Commitments and Contingencies - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/CommitmentsandContingenciesAdditionalInformationDetails </Role>
<ShortName> Commitments and Contingencies - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 69 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R70.htm </HtmlFileName>
<LongName> 9954515 - Disclosure - Commitments and Contingencies - Supplemental Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/CommitmentsandContingenciesSupplementalInformationDetails </Role>
<ShortName> Commitments and Contingencies - Supplemental Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 70 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R71.htm </HtmlFileName>
<LongName> 9954516 - Disclosure - Commitments and Contingencies - Lease Cost (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/CommitmentsandContingenciesLeaseCostDetails </Role>
<ShortName> Commitments and Contingencies - Lease Cost (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 71 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R72.htm </HtmlFileName>
<LongName> 9954517 - Disclosure - Commitments and Contingencies - Undiscounted Future Non-Cancellable Lease Payments Under Leases (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/CommitmentsandContingenciesUndiscountedFutureNonCancellableLeasePaymentsUnderLeasesDetails </Role>
<ShortName> Commitments and Contingencies - Undiscounted Future Non-Cancellable Lease Payments Under Leases (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 72 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R73.htm </HtmlFileName>
<LongName> 9954518 - Disclosure - Income Taxes - Domestic and Foreign Components of Income (Loss) (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IncomeTaxesDomesticandForeignComponentsofIncomeLossDetails </Role>
<ShortName> Income Taxes - Domestic and Foreign Components of Income (Loss) (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 73 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R74.htm </HtmlFileName>
<LongName> 9954519 - Disclosure - Income Taxes - Provision for Domestic and Foreign Income Taxes (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IncomeTaxesProvisionforDomesticandForeignIncomeTaxesDetails </Role>
<ShortName> Income Taxes - Provision for Domestic and Foreign Income Taxes (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 74 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R75.htm </HtmlFileName>
<LongName> 9954520 - Disclosure - Income Taxes - Effective Income Tax Rate Reconciliation (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IncomeTaxesEffectiveIncomeTaxRateReconciliationDetails </Role>
<ShortName> Income Taxes - Effective Income Tax Rate Reconciliation (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 75 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R76.htm </HtmlFileName>
<LongName> 9954521 - Disclosure - Income Taxes - Deferred Tax Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IncomeTaxesDeferredTaxAssetsDetails </Role>
<ShortName> Income Taxes - Deferred Tax Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 76 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R77.htm </HtmlFileName>
<LongName> 9954522 - Disclosure - Income Taxes - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IncomeTaxesAdditionalInformationDetails </Role>
<ShortName> Income Taxes - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 77 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R78.htm </HtmlFileName>
<LongName> 9954523 - Disclosure - Income Taxes - Unrecognized Tax Benefits (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/IncomeTaxesUnrecognizedTaxBenefitsDetails </Role>
<ShortName> Income Taxes - Unrecognized Tax Benefits (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 78 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R79.htm </HtmlFileName>
<LongName> 9954524 - Disclosure - Employee Benefits (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/EmployeeBenefitsDetails </Role>
<ShortName> Employee Benefits (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/EmployeeBenefits </ParentRole>
<Position> 79 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R80.htm </HtmlFileName>
<LongName> 9954525 - Disclosure - Acquisitions - Additional Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AcquisitionsAdditionalInformationDetails </Role>
<ShortName> Acquisitions - Additional Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 80 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R81.htm </HtmlFileName>
<LongName> 9954526 - Disclosure - Acquisitions - Acquisition Purchase Price (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AcquisitionsAcquisitionPurchasePriceDetails </Role>
<ShortName> Acquisitions - Acquisition Purchase Price (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 81 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R82.htm </HtmlFileName>
<LongName> 9954527 - Disclosure - Acquisitions - Fair Value of Tangible and Identifiable Assets Acquired and Liabilities Assumed (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AcquisitionsFairValueofTangibleandIdentifiableAssetsAcquiredandLiabilitiesAssumedDetails </Role>
<ShortName> Acquisitions - Fair Value of Tangible and Identifiable Assets Acquired and Liabilities Assumed (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 82 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R83.htm </HtmlFileName>
<LongName> 9954528 - Disclosure - Acquisitions - Identifiable Intangible Assets (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AcquisitionsIdentifiableIntangibleAssetsDetails </Role>
<ShortName> Acquisitions - Identifiable Intangible Assets (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 83 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R84.htm </HtmlFileName>
<LongName> 9954529 - Disclosure - Acquisitions - Pro Forma Information (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/AcquisitionsProFormaInformationDetails </Role>
<ShortName> Acquisitions - Pro Forma Information (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<Position> 84 </Position>
</Report>
<Report instance="bngo-20231231.htm">
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<HtmlFileName> R85.htm </HtmlFileName>
<LongName> 9954530 - Disclosure - Related Party Transactions (Details) </LongName>
<ReportType> Sheet </ReportType>
<Role> http://bionanogenomics.com/role/RelatedPartyTransactionsDetails </Role>
<ShortName> Related Party Transactions (Details) </ShortName>
<MenuCategory> Details </MenuCategory>
<ParentRole> http://bionanogenomics.com/role/RelatedPartyTransactions </ParentRole>
<Position> 85 </Position>
</Report>
<Report>
<IsDefault> false </IsDefault>
<HasEmbeddedReports> false </HasEmbeddedReports>
<LongName> All Reports </LongName>
<ReportType> Book </ReportType>
<ShortName> All Reports </ShortName>
</Report>
</MyReports>
<InputFiles>
<File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="bngo-20231231.htm"> bngo-20231231.htm </File>
<File> bngo-20231231.xsd </File>
<File> bngo-20231231_cal.xml </File>
<File> bngo-20231231_def.xml </File>
<File> bngo-20231231_lab.xml </File>
<File> bngo-20231231_pre.xml </File>
</InputFiles>
<SupplementalFiles>
<File> bngo-20231231_g1.jpg </File>
<File> bngo-20231231_g2.jpg </File>
<File> bngo-20231231_g3.jpg </File>
<File> bngo-20231231_g4.jpg </File>
<File> bngo-20231231_g5.jpg </File>
<File> bngo-20231231_g6.jpg </File>
<File> bngo-20231231_g7.jpg </File>
</SupplementalFiles>
<BaseTaxonomies>
<BaseTaxonomy items="1107"> http://fasb.org/us-gaap/2023 </BaseTaxonomy>
<BaseTaxonomy items="39"> http://xbrl.sec.gov/dei/2023 </BaseTaxonomy>
<BaseTaxonomy items="4"> http://xbrl.sec.gov/ecd/2023 </BaseTaxonomy>
</BaseTaxonomies>
<HasPresentationLinkbase> true </HasPresentationLinkbase>
<HasCalculationLinkbase> true </HasCalculationLinkbase>
</FilingSummary>

3 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/08/24  Bionano Genomics, Inc.            10-Q        3/31/24   69:8.3M
 5/08/24  Bionano Genomics, Inc.            S-8         5/08/24    4:100K                                   Broadridge Fin’l So… Inc
 4/08/24  Bionano Genomics, Inc.            424B5                  1:711K                                   Broadridge Fin’l So… Inc

23 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/28/24  Bionano Genomics, Inc.            8-K:1,7,9   2/27/24   13:252K                                   Broadridge Fin’l So… Inc
11/08/23  Bionano Genomics, Inc.            10-Q        9/30/23   71:8.4M
10/11/23  Bionano Genomics, Inc.            8-K:1,2,3,710/09/23   16:1.4M                                   Broadridge Fin’l So… Inc
 8/04/23  Bionano Genomics, Inc.            8-K:3,5,9   8/04/23   13:239K                                   Broadridge Fin’l So… Inc
 5/09/23  Bionano Genomics, Inc.            10-Q        3/31/23   67:7.4M
 4/14/23  Bionano Genomics, Inc.            8-K:1,3,5,9 4/13/23   14:325K                                   Broadridge Fin’l So… Inc
 3/09/23  Bionano Genomics, Inc.            10-K       12/31/22  104:13M
11/28/22  Bionano Genomics, Inc.            8-K:1,7,8,911/23/22   14:1.5M                                   Broadridge Fin’l So… Inc
 3/01/22  Bionano Genomics, Inc.            10-K       12/31/21  104:17M
10/19/21  Bionano Genomics, Inc.            8-K:2,9    10/18/21   12:1.2M                                   Broadridge Fin’l So… Inc
 8/04/21  Bionano Genomics, Inc.            10-Q        6/30/21   57:5.5M
 3/24/21  Bionano Genomics, Inc.            8-K:8,9     3/23/21   13:581K                                   Broadridge Fin’l So… Inc
 3/23/21  Bionano Genomics, Inc.            10-K       12/31/20   88:9.4M
11/13/20  Bionano Genomics, Inc.            10-Q        9/30/20   60:6.4M
 8/24/20  Bionano Genomics, Inc.            8-K:1,2,3,8 8/20/20    5:1.8M                                   Broadridge Fin’l So… Inc
 8/14/20  Bionano Genomics, Inc.            S-8         8/14/20    4:228K                                   Broadridge Fin’l So… Inc
 3/24/20  Bionano Genomics, Inc.            S-1/A                  6:1.2M                                   Broadridge Fin’l So… Inc
 9/18/19  Bionano Genomics, Inc.            S-1                    5:1.1M                                   Broadridge Fin’l So… Inc
 8/28/18  Bionano Genomics, Inc.            S-8         8/28/18    5:273K                                   Donnelley … Solutions/FA
 8/24/18  Bionano Genomics, Inc.            8-K:5,9     8/23/18    3:211K                                   Donnelley … Solutions/FA
 7/17/18  Bionano Genomics, Inc.            S-1/A                 13:4.3M                                   Donnelley … Solutions/FA
 7/13/18  Bionano Genomics, Inc.            S-1/A                  7:2.7M                                   Donnelley … Solutions/FA
 6/28/18  Bionano Genomics, Inc.            S-1                   43:9.3M                                   Donnelley … Solutions/FA
↑Top
Filing Submission 0001411690-24-000013   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., May 14, 3:33:05.2pm ET